Patient Guide: A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 19 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04398745
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma
Phase: PHASE1

Where You Can Participate

This study is available at 19 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Beverly Hills, California
  • • Sacramento, California
  • • And 16 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function - Join Clinical Trial NCTNCT04398745

How to Join This Clinical Trial - NCTNCT04398745

Learn how to participate in this PHASE1 trial studying an investigational therapy for Multiple Myeloma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple Myeloma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple Myeloma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04398745 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 19 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85724 - United States

Status: Contact for availability

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95817 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32224-3899 - United States

Status: Contact for availability

Clinical Research Site

Plantation, Florida 33322 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: Contact for availability

Clinical Research Site

Westwood, Kansas 66205 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21201-1595 - United States

Status: Contact for availability

Clinical Research Site

Chapel Hill, North Carolina 27514 - United States

Status: Contact for availability

Clinical Research Site

Portland, Oregon 97239 - United States

Status: Contact for availability

And 9 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Multiple Myeloma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships